Galena Biopharma Inc news

   Watch this stock
Showing stories 1 - 6 of about 6   

Articles published

GALE 1.32 -0.03 (-2.22%)
price chart
Galena Biopharma: Late Stage NeuVax Justifies Higher Valuation
Galena Biopharma (NASDAQ:GALE) is a biotechnology company focused on discovering, developing, and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics.
Training immune system to fight cancer comes of age
Others in advanced testing of such therapies include Vical Inc and NewLink Genetics. Investors spooked by .... Engelsgjerd favors Neuvax, a breast cancer vaccine being developed by Galena Biopharma that is intended for earlier-stage use following surgery.
Immunotherapy Drugs: Two Drugs Harness Immune System To Fight Cancer
NEW YORK, May 7 (Reuters) - More than 100 years after researchers first explored the potential to harness the body's immune system to fight cancer, the field's leading doctors see the concept finally proving itself on a large scale in the next year or two.
Critical Success Factors For The Immunotherapy Race
Previously we covered differing approaches taken by emerging and innovative publicly traded companies in the cancer vaccine space.
Time To Go Nuts With Diamond Foods
Contrarian investors live for the moments when the Wall Street herd becomes homogeneously euphoric or pessimistic. With everyone betting on the same outcome, the market prices these situations for perfection with no "margin of safety" should the ...
Breakthrough in immunotherapy, could cure cancer
Others in advanced testing of such therapies include Vical Inc and NewLink Genetics . Investors spooked .... Engelsgjerd favors Neuvax, a breast cancer vaccine being developed by Galena Biopharma that is intended for earlier-stage use following surgery.